Benitec Biopharma Limited 3Y Revenue Growth (per Share)

3Y Revenue Growth (per Share) of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including 3Y Revenue Growth (per Share) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 3Y Revenue Growth (per Share) for 2022 was -55.31% (a -115.8% decrease from previous year)
  • Annual 3Y Revenue Growth (per Share) for 2021 was 350.07% (a -454.14% decrease from previous year)
  • Annual 3Y Revenue Growth (per Share) for 2021 was -98.85% (a -246.81% decrease from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 3Y Revenue Growth (per Share) of Benitec Biopharma Limited

Most recent 3Y Revenue Growth (per Share)of BNTC including historical data for past 10 years.

Interactive Chart of 3Y Revenue Growth (per Share) of Benitec Biopharma Limited

Benitec Biopharma Limited 3Y Revenue Growth (per Share) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -55.31%
2021 350.07%
2020 67.33%
2019 2681.72%
2018 2251.55%
2017 0.0%
2016 14.13%
2015 2210.89%
2014 -12.38%
2013 0.0%

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology